复星医药(600196)披露为控股子公司提供担保的进展公告,10月16日股价上涨1.92%

中金财经
Oct 16, 2025

  h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年10月16日收盘,复星医药(600196)报收于29.15元,较前一交易日上涨1.92%,最新总市值为778.43亿元。该股当日开盘28.56元,最高29.4元,最低28.48元,成交额达9.76亿元,换手率为1.59%。公司近日发布公告称,上海复星医药(集团)股份有限公司为控股子公司提供担保,涉及复星医药产业、复星健康、徐州星晨医院、复星安特金、武汉健嘉、长沙健嘉、佛山健嘉、济南健源、南昌健源等9家子公司,担保金额合计人民币119,350万元。本次担保均在前期预计额度内,部分被担保方资产负债率超过70%。截至2025年10月15日,集团实际对外担保余额约2,337,703万元,占2024年末经审计净资产的49.46%,无逾期担保。担保事项已履行内部决策程序,无需另行审批。所有担保均为集团内公司间担保,部分担保设有反担保。最新公告列表《复星医药关于为控股子公司提供担保的进展公告》为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10